EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Amino acid and protein Sources: 4

L-carnitine

Also called: carnitine, acetyl-L-carnitine, propionyl-L-carnitine, levocarnitine

An amino acid-derived compound that transports long-chain fatty acids into mitochondria. The liver, kidneys and brain make it from lysine and methionine; red meat is the main dietary source. About 95% is stored in heart and skeletal muscle.

Category
Amino acid and protein
Forms
L-carnitine and acetyl-L-carnitine (main supplement forms); propionyl-L-carnitine
Strongest evidence
B Some positive trials
Reviewed
2026-10-28

Class 1 Well studied in people. A 2024 meta-analysis (Diabetol Metab Syndr) pooled 21 RCTs (2,900 participants with impaired glucose tolerance or diabetes) of oral L-carnitine versus placebo or no L-carnitine; some trials added L-carnitine to orlistat, sibutramine or simvastatin given to both arms. [3]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

6 topics studied5 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what L-carnitine does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for L-carnitine, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood glucose control in type 2 diabetes or insulin resistanceBA 2023 meta-analysis of 41 trials (about 2,900 participants) found lower fasting glucose, insulin resistance and HbA1c; ODS states larger trials are needed. [1]
Outcomes after acute myocardial infarctionBA meta-analysis of 13 trials (3,629 adults) found lower all-cause mortality, ventricular arrhythmias and new angina, but no effect on heart failure or reinfarction. [1]
Body weightBA 2016 meta-analysis of 9 trials (911 participants) found an average 1.33 kg greater weight loss than placebo. [1]
Sperm quality and fertility in menBA 2022 Cochrane review (6 trials, 1,089 men) found improved sperm motility and concentration at some time points, but no effect on live birth or pregnancy rates. [1]
Athletic performanceCEvidence is mixed: reviews found some benefits, such as lower lactate and faster recovery, while other studies showed no effect. [1]
Mild cognitive impairment and Alzheimer's disease (acetyl-L-carnitine)CA 2003 Cochrane review of 11 trials in Alzheimer’s disease found more people improved on clinical global impression with acetyl-L-carnitine at 12 and 24 weeks but not at 52 weeks, no benefit on objective measures, and no evidence to recommend routine use. [4]

Main constituents: L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Supplements provide about 3 mg to 5,000 mg. Typical omnivorous diets provide about 24-145 mg/day; vegan diets about 1.2 mg/day. [1]
  • For primary and secondary carnitine deficiency, ODS describes high doses of 20-200 mg/kg/day of supplemental carnitine, used under medical care. [1]

Upper limits

  • No Dietary Reference Intakes or UL have been established; healthy people make enough carnitine and do not need it from food or supplements. [1]
Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Health Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    2 listed

    Pivalate-conjugated antibiotics (such as pivampicillin); Anticonvulsants (valproic acid, phenobarbital, phenytoin, carbamazepine)

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    3 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada (monograph dated July 25, 2025), adults 18 and older: not to exceed 4 grams of L-carnitine per day (antioxidant use) or 1-4 grams per …

    Details and sources
  • Doses of about 3 g/day can cause nausea, vomiting, abdominal cramps, diarrhea and a fishy body odor. [1]
  • Carnitine can cause muscle weakness in people with uremia and seizures in people with seizure disorders. [1]
  • Gut bacteria convert unabsorbed carnitine to TMAO, which may increase cardiovascular disease risk; the implications are not well understood. [1]
Interactions

Interactions

L-carnitine
From the table below 2 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of L-carnitine
WithWhat happens
Pivalate-conjugated antibiotics (such as pivampicillin)Chronic use can deplete carnitine; no illness from this deficiency has been described. [1]
Anticonvulsants (valproic acid, phenobarbital, phenytoin, carbamazepine)These drugs reduce blood carnitine levels. Intravenous L-carnitine may help in valproate toxicity, but the optimal regimen is not identified. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • Absorption of supplemental L-carnitine is about 14-18%, compared with about 63-75% for carnitine from food. [1]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [2]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine Supplement forms named by ODS [P1]
  • L-Carnitine (levocarnitine); supplement sources L-carnitine, L-carnitine fumarate and L-carnitine tartrate Proper name: (R)-3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 3 entries naming carnitine (earliest NDI 248 submitted 2003-08-13; most recent NDI 769 submitted 2012-08-06). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P3]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of L-carnitine was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P4]
  • NTP technical reports list checked 2026-10-29: no report on carnitine. [P5]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • Pivalate-conjugated antibiotics (such as pivampicillin): Chronic use can deplete carnitine; no illness from this deficiency has been described. [P1]
  • Anticonvulsants (valproic acid, phenobarbital, phenytoin, carbamazepine): These drugs reduce blood carnitine levels. [P1]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P6]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • Absorption of supplemental L-carnitine is about 14-18%, compared with about 63-75% for carnitine from food; some research indicates that intestinal bacteria metabolize unabsorbed carnitine to TMAO and gamma-butyrobetaine. [P1]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada (monograph dated July 25, 2025), adults 18 and older: not to exceed 4 grams of L-carnitine per day (antioxidant use) or 1-4 grams per day (muscle recovery and athletic support uses), in each case not to exceed 2 grams per single dose. [P2]

Pregnancy and breastfeeding

  • Health Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding. [P2]

Sources for this profile

  1. NIH Office of Dietary Supplements. Carnitine: Fact Sheet for Health Professionals (Updated: April 17, 2023), 2023-04-17. ods.od.nih.gov
  2. Health Canada, NNHPD. Monograph: L-Carnitine (date 2025-07-25), 2025-07-25. webprod.hc-sc.gc.ca
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  5. National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  6. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources

Sources

  1. NIH Office of Dietary Supplements. Carnitine: Fact Sheet for Health Professionals (Updated: April 17, 2023), 2023-04-17. ods.od.nih.gov
  2. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
  3. Gheysari R, et al. The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance and diabetes: a systematic review and dose-response meta-analysis. Diabetol Metab Syndr 2024;16(1):185 (PMID 39085907), 2024-07-31. pubmed.ncbi.nlm.nih.gov
  4. Hudson S, Tabet N. Acetyl-L-carnitine for dementia. Cochrane Database Syst Rev 2003;(2):CD003158 (PMID 12804452), 2003-04-22. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.